Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- US Study Shows Good Results for NM-702 Against ASO
March 27, 2006
- SELF-MEDICATION NEWS IN BRIEF
March 27, 2006
- Takeda Announces License Agreement for Tavocept in Japan
March 27, 2006
- 3 Bioventures to Jointly Develop Anticancer Agents
March 27, 2006
- MEDICAL DEVICE NEWS IN BRIEF
March 27, 2006
- NPhA Criticizes Takeda's Attitude toward Chain Pharmacies
March 27, 2006
- Korosho Submits Proposed GL for Animal Studies
March 27, 2006
- Hokuyaku, Takeyama to Integrate Management
March 27, 2006
- R&D NEWS IN BRIEF
March 27, 2006
- BUSINESS NEWS IN BRIEF
March 27, 2006
- JPMA Health Policy Seminar
March 27, 2006
- Korosho Calls For Stable, Nationwide Supply of Generics at All Strengths
March 27, 2006
- Seminar
March 27, 2006
- Notification on Measures to Promote the Use of Generics Issued
March 27, 2006
- Seminar
March 27, 2006
- Towa, Sawai, and Nichi-iko Will Cooperate to Supply All Specifications
March 27, 2006
- New 3-year Regulatory Reform Plan Coming Soon
March 27, 2006
- Taiyo to Independently Supply All Specifications
March 27, 2006
- REGULATORY NEWS IN BRIEF
March 27, 2006
- JGPMA to Distribute "GE Drug Consultation Card" Free of Charge
March 27, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…